AAAAAA
Results:
1-21
|
Results: 21
Authors:
Strater, J
Walczak, H
Hasel, C
Melzner, I
Leithauser, F
Moller, P
Citation: J. Strater et al., CD95 ligand (CD95L) immunohistochemistry: a critical study on 12 antibodies, CELL DEAT D, 8(3), 2001, pp. 273-278
Authors:
Walczak, H
Sprick, MR
Citation: H. Walczak et Mr. Sprick, Biochemistry and function of the DISC, TRENDS BIOC, 26(7), 2001, pp. 452-453
Authors:
Rohn, TA
Wagenknecht, B
Roth, W
Naumann, U
Gulbins, E
Krammer, PH
Walczak, H
Weller, M
Citation: Ta. Rohn et al., CCNU-dependent potentiation of TRAIL/Apo2L-induced apoptosis in human glioma cells is p53-independent but may involve enhanced cytochrome c release, ONCOGENE, 20(31), 2001, pp. 4128-4137
Authors:
Trauzold, A
Wermann, H
Arlt, A
Schutze, S
Schafer, H
Oestern, S
Roder, C
Ungefroren, H
Lampe, E
Heinrich, M
Walczak, H
Kalthoff, H
Citation: A. Trauzold et al., CD95 and TRAIL receptor-mediated activation of protein kinase C and NF-kappa B contributes to apoptosis resistance in ductal pancreatic adenocarcinoma cells, ONCOGENE, 20(31), 2001, pp. 4258-4269
Authors:
Simon, AK
Williams, O
Mongkolsapaya, J
Jin, B
Xu, XN
Walczak, H
Screaton, GR
Citation: Ak. Simon et al., Tumor necrosis factor-related apoptosis-inducing ligand in T cell development: Sensitivity of human thymocytes, P NAS US, 98(9), 2001, pp. 5158-5163
Authors:
Schmitz, I
Walczak, H
Krammer, PH
Peter, ME
Citation: I. Schmitz et al., The two CD95 apoptosis signaling pathways may be a way of cells to respondto different amounts and/or forms of CD95 ligand produced in different tissues, CELL DEAT D, 7(8), 2000, pp. 756-758
Authors:
Wendling, U
Walczak, H
Dorr, J
Jaboci, C
Weller, M
Krammer, PH
Zipp, F
Citation: U. Wendling et al., Expression of TRAIL receptors in human autoreactive and foreign antigen-specific T cells, CELL DEAT D, 7(7), 2000, pp. 637-644
Authors:
Dejosez, M
Ramp, U
Mahotka, C
Krieg, A
Walczak, H
Gabbert, HE
Gerharz, CD
Citation: M. Dejosez et al., Sensitivity to TRAIL/APO-2L-mediated apoptosis in human renal cell carcinomas and its enhancement by topotecan, CELL DEAT D, 7(11), 2000, pp. 1127-1136
Authors:
Sprick, MR
Weigand, MA
Rieser, E
Rauch, CT
Juo, P
Blenis, J
Krammer, PH
Walczak, H
Citation: Mr. Sprick et al., FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2, IMMUNITY, 12(6), 2000, pp. 599-609
Authors:
Hinz, S
Trauzold, A
Boenicke, L
Sandberg, C
Beckmann, S
Bayer, E
Walczak, H
Kalthoff, H
Ungefroren, H
Citation: S. Hinz et al., Bcl-X-L protects pancreatic adenocarcinoma cells against CD95-and TRAIL-receptor-mediated apoptosis, ONCOGENE, 19(48), 2000, pp. 5477-5486
Authors:
Funk, JO
Walczak, H
Voigtlander, C
Berchtold, S
Baumeister, T
Rauch, P
Rossner, S
Steinkasserer, A
Schuler, G
Lutz, MB
Citation: Jo. Funk et al., Cutting edge: Resistance to apoptosis and continuous proliferation of dendritic cells deficient for TNF receptor-1, J IMMUNOL, 165(9), 2000, pp. 4792-4796
Authors:
Keogh, SA
Walczak, H
Bouchier-Hayes, L
Martin, SJ
Citation: Sa. Keogh et al., Failure of Bcl-2 to block cytochrome c redistribution during TRAIL-inducedapoptosis, FEBS LETTER, 471(1), 2000, pp. 93-98
Authors:
Walczak, H
Krammer, PH
Citation: H. Walczak et Ph. Krammer, The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems, EXP CELL RE, 256(1), 2000, pp. 58-66
Authors:
Bouchon, A
Krammer, PH
Walczak, H
Citation: A. Bouchon et al., Critical role for mitochondria in B cell receptor-mediated apoptosis, EUR J IMMUN, 30(1), 2000, pp. 69-77
Authors:
Leverkus, M
Neumann, M
Mengling, T
Rauch, CT
Brocker, EB
Krammer, PH
Walczak, H
Citation: M. Leverkus et al., Regulation of tumor necrosis factor-related apoptosis-inducing ligand sensitivity in primary and transformed human keratinocytes, CANCER RES, 60(3), 2000, pp. 553-559
Authors:
Walczak, H
Bouchon, A
Stahl, H
Krammer, PH
Citation: H. Walczak et al., Tumor necrosis factor-related apoptosis-inducing ligand retains its apoptosis-inducing capacity on Bcl-2-or Bcl-x(L)-overexpressing chemotherapy-resistant tumor cells, CANCER RES, 60(11), 2000, pp. 3051-3057
Authors:
Leverkus, M
Walczak, H
McLellan, A
Fries, HW
Terbeck, G
Brocker, EB
Kampgen, E
Citation: M. Leverkus et al., Maturation of dendritic cells leads to up-regulation of cellular FLICE-inhibitory protein and concomitant down-regulation of death ligand-mediated apoptosis, BLOOD, 96(7), 2000, pp. 2628-2631
Fluorogenic substrates as detectors of caspase activity during natural killer cell-induced apoptosis
Authors:
Los, M
Walczak, H
Schulze-Osthoff, K
Reed, JC
Citation: M. Los et al., Fluorogenic substrates as detectors of caspase activity during natural killer cell-induced apoptosis, METH MOL B, 121, 2000, pp. 155-162
Authors:
Schmitz, I
Walczak, H
Krammer, PH
Peter, ME
Citation: I. Schmitz et al., Differences between CD95 type I and type II cells detected with the CD95 ligand, CELL DEAT D, 6(9), 1999, pp. 821-822
Authors:
Walczak, H
Miller, RE
Ariail, K
Gliniak, B
Griffith, TS
Kubin, M
Chin, W
Jones, J
Woodward, A
Le, T
Smith, C
Smolak, P
Goodwin, RG
Rauch, CT
Schuh, JCL
Lynch, DH
Citation: H. Walczak et al., Tumoricidal activity of tumor necrosis factor related apoptosis-inducing ligand in vivo, NAT MED, 5(2), 1999, pp. 157-163
Authors:
Strater, J
Mariani, SM
Walczak, H
Rucker, FG
Leithauser, F
Krammer, PH
Moller, P
Citation: J. Strater et al., CD95 ligand (CD95L) in normal human lymphoid tissues - A subset of plasma cells are prominent producers of CD95L, AM J PATH, 154(1), 1999, pp. 193-201
Risultati:
1-21
|